Dergiler / Medicine Science / 2016 / Cilt: 5 - Sayı: 2

May Lymphadenectomy be Omitted in Granulosa Cell Tumors of the Ovary?

Sayfa
496–504
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

So that omitting lymphadenectomy could be an option for GCTs if a low mitotic index (<5/10HPF), negative LVSI or mild atypia with a mass not larger than 10 cm.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Granulosa cell tumors (GCTs) of the ovary are rare tumors and they are generally detected in early stages with a favorable prognosis.
📊
Temel Bulgular & Veri:Women with adult type granulosa cell tumor pathology result between March 2007 and April 2013 were evaluated retrospectively using computerized database of the institution.
💡
Sonuç & Katkı:So that omitting lymphadenectomy could be an option for GCTs if a low mitotic index (<5/10HPF), negative LVSI or mild atypia with a mass not larger than 10 cm.
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:2007 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Granulosa cell tumors (GCTs) of the ovary are rare tumors and they are generally detected in early stages with a favorable prognosis. However, the controversies over the extend of surgery are still judging the surgical management. We retrospectively evaluated demographic and clinical variables of granulosa cell tumors of the ovary with probable prognostic factors to identify the clinicopathological features. Women with adult type granulosa cell tumor pathology result between March 2007 and April 2013 were evaluated retrospectively using computerized database of the institution. Age, stage, menopausal status, parity, clinical presentation, surgical procedures, histopathologic results, preoperative tumor markers, tumor diameter and laterality were the reviewed parameters. Patients were staged according to the International Federation of Gynecology and Obstetrics (FIGO) staging system for ovarian tumors that was revised in 2014. A total of 40 patients were retrospectively evaluated. We further categorized patients as stage 1A and more advanced stage disease. Twenty-seven patients (67.5%) were within Stage 1A disease and 13 (32.5%) patients had more advanced stage of disease. Only one patient had retroperitoneal lymph node involvement and recurred 2 years after the completion of the chemotherapy, and died of disease after 2 years from recurrence. Since the risk of unintended complications and morbidity, which is related with lymph node dissection, the rare incidence of lymph node involvement should be kept on mind. So that omitting lymphadenectomy could be an option for GCTs if a low mitotic index (<5/10HPF), negative LVSI or mild atypia with a mass not larger than 10 cm.

🔖

Bu Makaleye Atıf Yap

ÖZ, M., SELÇUK, İ., ÖZDAL, B., BİBEROĞLU, E., BAŞ, S., MEYDANL, M. M., AKBAY, S., GÜNGÖR, T. (2016). May Lymphadenectomy be Omitted in Granulosa Cell Tumors of the Ovary?. Medicine Science, Cilt: 5 - Sayı: 2, 496–504. https://ajindex.com/articles/277533

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Schumer ST, Cannistra SA. Granulosa cell tumor of the ovary. J Clin Oncol. 2003;21(6):1180-9
  2. Segal R, DePetrillo AD, Thomas G. Clinical review of adult granulosa cell tumors of the ovary. Gynecol Oncol. 1995;56(3):338-44
  3. Ayhan A, Salman MC, Velipasaoglu M, Sakinci M, Yuce K. Prognostic factors in adult granulosa cell tumors of the ovary: a retrospective analysis of 80 cases. J Gynecol Oncol. 2009;20(3):158-63
  4. Evans AT, 3rd, Gaffey TA, Malkasian GD, Jr., Annegers JF. Clinicopathologic review of 118 granulosa and 82 theca cell tumors. Obstet Gynecol. 1980;55(2):231-8
  5. Pectasides D, Papaxoinis G, Fountzilas G, Aravantinos G, Pectasides E, Mouratidou D Economopoulos T, Andreadis Ch. Adult granulosa cell tumors of the ovary: a clinicopathological study of 34 patients by the Hellenic Cooperative Oncology Group (HeCOG). Anticancer Res. 2008;28(2B):1421-7
  6. Lee IH, Choi CH, Hong DG, Song JY, Kim YJ, Kim KT Lee KW, Park IS, Bae DS, Kim TJ. Clinicopathologic characteristics of granulosa cell tumors of the ovary: a multicenter retrospective study. J Gynecol Oncol. 2011;22(3):188-95
  7. Shim SH, Lee SJ, Kim DY, Kim J, Kim SN, Kim JH, Kim YM, Kim YT, Nam JH. A Long-term follow-up study of 91 cases with ovarian granulosa cell tumors. Anticancer Res. 2014;34(2):1001-10
  8. Kottarathil VD, Antony MA, Nair IR, Pavithran K. Recent advances in granulosa cell tumor ovary: a review. Indian J Surg Oncol. 2013;4(1):37-47
  9. Huang BS, Sun HD, Hsu YM, Chang WH, Horng HC, Yen MS, Chao KC, Edmond Hsieh SL, Wang PH. Clinical presentation and outcome of adult-type granulosa cell tumors: a retrospective study of 30 patients in a single institute. J Chin Med Assoc. 2014;77(1):21-5
  10. Lappohn RE, Burger HG, Bouma J, Bangah M, Krans M, de Bruijn HW. Inhibin as a marker for granulosa-cell tumors. N Engl J Med. 1989;321(12):790-3
  11. Mangili G, Ottolina J, Gadducci A, Giorda G, Breda E, Savarese A, Candiani M, Frigerio L, Scarfone G, Pignata S, Rossi R, Marinaccio M, Lorusso D. Long-term follow-up is crucial after treatment for granulosa cell tumours of the ovary. Br J Cancer. 2013;109(1):29-34
  12. Suri A, Carter EB, Horowitz N, Denslow S, Gehrig PA. Factors associated with an increased risk of recurrence in women with ovarian granulosa cell tumors. Gynecol Oncol. 2013;131(2):321-4
  13. Khosla D, Dimri K, Pandey AK, Mahajan R, Trehan R. Ovarian granulosa cell tumor: clinical features, treatment, outcome, and prognostic factors. N Am J Med Sci. 2014;6(3):133-8